Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
- Conditions
- IUD
- Registration Number
- NCT06891794
- Lead Sponsor
- Oregon Health and Science University
- Brief Summary
This prospective, open label, double arm, feasibility group study will recruit participants planning to undergo office intrauterine device (IUD) placement without sedation or anxiolysis at the Center for Women's Health. Participants will self-administer a topical anesthetic using a contraceptive cervical cap or menstrual disc.
Twenty-four nulliparous women will be recruited to receive one of two administration methods immediately prior to IUD placement (12 subjects in each arm): 1) menstrual disc filled with 5g eutectic mixture of local anesthetics (EMLA) cream or 2) cervical cap filled with 5g EMLA cream.
- Detailed Description
Nulliparous patients undergoing IUD insertion will administer EMLA cream by menstrual disc or cervical cap prior to insertion. The medical provider will ensure proper placement of the cap or disc and perform a bi-manual exam to assess the patient's uterine position. A seven minute timer will be set, the cap/disc will be removed, and the provider will proceed with the IUD insertion according to manufacturer technique.
Visual Analog Scale (VAS) scores will be used throughout the procedure to assess participant pain throughout insertion. Participants and providers will report on pain, side effects, and procedure complications immediately after the procedure.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 24
- Scheduled for IUD placement at the Center for Women's Health in Complex Family Planning clinic
- Able to review and sign study consents in English
- Generally healthy
- History of any prior births, miscarriages, or abortions after 16 weeks' gestation
- Currently pregnant, known or suspected
- Current stringless IUD in place
- Participants premedicated with misoprostol
- History of chronic pelvic pain which patients take daily medication for
- History of endometriosis, fibroids, adenomyosis, prior cervical procedures (such as Loop Electrosurgical Excision Procedure (LEEP) or cold knife cone)
- Any contraindications to IUD placement (per current labeling including pregnancy, fibroids that distort the uterine cavity, exam consistent with pelvic inflammatory disease, allergy to any component of the levonorgestrel intrauterine system (LNG-IUS), etc.)
- Known allergy to eutectic mixture of local anesthetics (EMLA) or lidocaine cream, silicone, menstrual disc, or cervical cap
- Any contraindication to EMLA or lidocaine cream, menstrual disc, or cervical cap
- Previous IUD placement or failed attempt of an IUD placement
- Weight < 54.4kg (120 lbs)
- Plan for use of oral anxiolysis, moderate/deep sedation, or narcotics for procedure
- Patient requesting or patient use in the past 24 hours of oral anxiolysis, moderate/deep sedation, or narcotics
- Any planned concomitant procedures, such as dilation and curettage (D&C), endometrial biopsy, colposcopy, hysteroscopy, etc.
- Illicit drug use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Successful Placement Immediately after IUD placement procedure The number of participants able to correctly place the cap or disc as instructed, assessed by provider
Satisfaction with pain control Immediately after IUD placement procedure Participant-reported satisfaction with pain control for IUD placement using EMLA cream measured the Patient Acceptable Symptom State (PASS) methodology.
- Secondary Outcome Measures
Name Time Method Ease of cap/disc placement Immediately after IUD placement procedure Participant-reported ease of placement of menstrual cap or disc. Response options will be "very easy", "somewhat easy", "neutral", "somewhat difficult", and "very difficult".
Protocol deviations Immediately after IUD placement procedure Provider-reported deviations from the standard protocol including need for additional analgesia, oral pain medication, oral anxiolytic medication, need for cervical dilation, rescheduling with sedation per patient preference, or other.
Ease of IUD placement Immediately after IUD placement procedure Provider-reported ease of IUD placement with response options "usual", "difficult", or "very difficult"
Procedure complications Immediately after IUD placement procedure Provider-reported complications of IUD placement procedure including vagal reaction, perforation, placement failure, allergic reaction, or other.
Typical menstrual pain On the day of IUD placement procedure prior to cap/disc placement and IUD placement Patient-reported numerical rating scale of their menstrual pain
Pain during IUD placement procedure Measured throughout IUD placement procedure immediately before the procedure, during placement of disc/cap, during speculum placement, during tenaculum placement, during sounding, during IUD placement, and 5 minutes after completion Patient-reported pain using Visual Analog Scale throughout IUD placement procedure
Acceptability of pain mangement one day post-procedure Patient-reported acceptability of pain management measured by a 5-point Likert scale question. Participants will be asked "How would you rate your satisfaction with the pain control during your IUD placement?". Response options range from very satisfied to very dissatisfied.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.